This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Clinical Laserthermia Systems Valuation

Is CLS UR B undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of CLS UR B when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate CLS UR B's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate CLS UR B's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for CLS UR B?

Other financial metrics that can be useful for relative valuation.

The above table shows the n/a ratio for CLS UR B. This is calculated by dividing CLS UR B's market cap by their current preferred multiple.
What is CLS UR B's n/a Ratio?
n/a	0x
n/a	n/a
Market Cap	SEK 22.31m

CLS UR B key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	2.5x
Enterprise Value/EBITDA	-0.2x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does CLS UR B's PS Ratio compare to its peers?

The above table shows the PS ratio for CLS UR B vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	3.4x
MONI Monivent	4.5x	n/a	SEK 16.5m
MEDF Medfield Diagnostics	3.3x	n/a	SEK 23.6m
ZENI Zenicor Medical Systems	0.8x	n/a	SEK 26.9m
ODIN Odinwell	5x	n/a	SEK 24.0m
CLS UR B Clinical Laserthermia Systems	3.6x	56.5%	SEK 22.3m

Price-To-Sales vs Peers: CLS UR B is good value based on its Price-To-Sales Ratio (3.6x) compared to the peer average (6.6x).

Price to Earnings Ratio vs Industry

How does CLS UR B's PE Ratio compare vs other companies in the SE Medical Equipment Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	27.0%
	n/a	n/a	n/a

Fetching data

0 Companies	Price / Earnings	Estimated Growth	Market Cap
Industry Avg.	n/a	27.0%
	n/a	n/a	n/a

No more companies

Price-To-Sales vs Industry: CLS UR B is good value based on its Price-To-Sales Ratio (3.6x) compared to the Swedish Medical Equipment industry average (6.9x)

Price to Sales Ratio vs Fair Ratio

What is CLS UR B's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

CLS UR B PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	3.6x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate CLS UR B's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.